• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

BioMedinvest

edit

BioMedInvest AG is a healthcare-dedicated venture capital fund based in Switzerland, providing private equity financing to early- to mid-stage companies in Switzerland and neighbouring regions (Alpine Rim). BioMedInvest currently invests out of Fund I, which has a size of CHF 100 million and was closed in 2003.

Recent Milestones

edit

• 
  BioMedinvest invested in Spinelab. (5/31/12)
  Posted 5/31/12 at 4:56am via pehub.com
• 
  BioMedinvest invested in Delenex Therapeutics. (5/3/11)
  Posted 5/3/11 at 6:04pm via finsmes.com
• 
  BioMedinvest invested in Anergis. (3/28/11)
  Posted 3/28/11 at 7:59pm via fiercebiotech.com
• 
  BioMedinvest invested in NovaShunt. (3/9/11)
  Posted 3/9/11 at 5:57am via prnewswire.com
• 
  BioMedinvest invested in Delenex Therapeutics. (11/12/10)
  Posted 11/14/10 at 6:38pm via finsmes.com
• 
  BioMedinvest invested in Affimed Therapeutics. (4/29/10)
  Posted 5/4/10 at 11:05pm via fiercebiotech.com
• 
  BioMedinvest invested in Evolva. (12/11/09)
  Posted 12/16/09 at 1:16am via dowjones.com
• 
  BioMedinvest invested in ESBATech. (8/7/08)
  Posted 6/24/09 at 12:46am via fiercebiotech.com
• 
  BioMedinvest invested in idiag. (10/17/07)
  Posted 3/17/10 at 3:12am
• 
  BioMedinvest invested in ESBATech. (8/2/06)
  Posted 4/19/10 at 7:51pm via esbatech.com

Investments

Videos

Sources

1. Spinelab Raises Series C from BioMedInvest and VI Partners Leads (pehub.com) [edit]
2. Delenex Therapeutics Raises $19.3M (finsmes.com) [edit]
3. Startup biotech lands $20M A round for Ph2 allergy trial (fiercebiotech.com) [edit]
4. NovaShunt AG Raises $25 Million in a Series B Financing Co-Led by BioMedInvest AG, Entrepreneurs Fund and Capricorn Health-tech Fund (prnewswire.com) [edit]
5. Delenex Therapeutics Closes CHF13.5M Series A Venture Capital Financing Round (finsmes.com) [edit]
6. Affimed raises €20M to fund innovative antibody trials (fiercebiotech.com) [edit]
7. Evolva Goes Public In Reverse Merger, Raises $43M (fis.dowjones.com) [edit]
8. ESBATech rounds up $22M in second round (fiercebiotech.com) [edit]
9. EDGAR [edit]
10. ESBATech Closes USD 41M Series B Venture Financing (esbatech.com) [edit]